Pradofloxacin, sold under the brand name Veraflox among others, is a third-generation enhanced spectrum veterinary antibiotic of the fluoroquinolone class.[5] It was developed by Elanco Animal Health GmbH and received approval from the European Commission in April 2011, for prescription-only use in veterinary medicine for the treatment of bacterial infections in dogs and cats.[6]
^"Veraflox Product information". Health Canada. 19 May 2022. Retrieved 12 April 2024.
^"Veraflox- pradofloxacin suspension". DailyMed. 14 October 2022. Retrieved 12 April 2024.
Pradofloxacin, sold under the brand name Veraflox among others, is a third-generation enhanced spectrum veterinary antibiotic of the fluoroquinolone class...
bactericidal activity; however, its efficacy is not as good as enrofloxacin or pradofloxacin. In 1997, the United States Food and Drug Administration approved difloxacin...
The chemical structure of finafloxacin is nearly identical to that of pradofloxacin. The synthesis of finafloxacin has been described in detail in its patents...